| Literature DB >> 32455345 |
Alaina P Vidmar1, Michael I Goran1, Jennifer K Raymond1.
Abstract
BACKGROUND: Time Limited Eating (TLE) is an effective strategy for management of obesity in adults, but there is a paucity of data that have examined its use in the clinical management of children with obesity. A TLE approach involves interspersing normal daily caloric intake with periods of prolonged calorie restriction several times per week. TLE may actually be more feasible, non-stigmatizing, flexible and effective in children, especially for adolescents, compared to alternatives like daily caloric or macronutrient restriction. This is because TLE removes the need for intensive counting of daily calorie intake or macronutrient content and focuses on a straightforward task of consuming food during a pre-specified time period. Also it avoids periods of extended caloric restriction which may interfere with growth and/or risk evoking development of eating behaviors. This case series describes four patients who trialed a TLE approach in a clinical weight management clinic and describes BMI reduction at 4 months. CASEEntities:
Keywords: Obesity; Pediatrics; Time Limited Eating
Year: 2019 PMID: 32455345 PMCID: PMC7243444 DOI: 10.26502/jfsnr.2642-11000022
Source DB: PubMed Journal: J Food Sci Nutr Res ISSN: 2642-1100
Anthropometry and biochemistry at baseline and 4 months in pediatric patients with obesity following a time limited eating dietary approach.
| Lab Tests | Case 1: 5 yo | Case 2: 12 yo | Case 3: 11 yo | Case 4: 15 yo | ||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 6 mo | Baseline | 6 mo | Baseline | 6 mo | Baseline | 6 mo | |
| Anthropometry | ||||||||
| BMI z score (SD) | 2.57 | 2.18 | 2.47 | 2.15 | 2.64 | 2.54 | 2.24 | 2.16 |
| BMI % 95th percentile (percent) | 125 | 110 | 140 | 120 | 150 | 140 | 110 | 95 |
| Blood Pressure | ||||||||
| Systolic blood pressure, mm Hg | 104 | 94 | 117 | 107 | 128 | 114 | 126 | 125 |
| Diastolic blood pressure, mm Hg | 54 | 55 | 58 | 53 | 85 | 76 | 76 | 73 |
| Biochemistry (Plasma) | ||||||||
| Fasting Plasma Glucose, mg/dL | 95 | 85 | 85 | 76 | 294 | 118 | 80 | 84 |
| ALT, U/L | 32 | 6 | 13 | 12 | 209 | 204 | 53 | 30 |
| AST, U/L | 32 | 46 | 14 | 15 | 158 | 209 | 34 | 33 |
| Total Cholesterol, mg/dL | - | - | 128 | 101 | 294 | 258 | 174 | 180 |
| Triglyceride, mg/dL | - | - | 141 | 90 | 224 | 188 | 200 | 153 |
| HDL, mg/dL | - | - | 42 | 45 | 30 | 33 | 26 | 26 |
| LDL, mg/dL | - | - | 58 | 51 | 167 | 110 | 120 | 125 |
Figure 1:Change in BMI Z-score across intervention period compared to baseline across the 4 patients reported. All 4 patients exhibited a down trend in their zBMI at 4 months compared to baseline.